Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

uniqFEED AG

History from 27 Jul 2016

UID
CHE-264.750.004
Legal form
AG
Canton
ZH
Founded
not in the record
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 649k
162k325k487k649k17 Mar 2020 · CHF 436k13 Oct 2022 · CHF 568k5 Aug 2026 · CHF 649k2020202120222023202420252026
  • shares

Record

  1. SHAB published 17 Mar 2020 · legal date 10 Mar 2020

    Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    214’416 → 436’133
    Shares
    214’416 → 436’133
    New shares, % of post-step shares
    50.8% (221’717 new)

    Aktienkapital neu: CHF 436'133.00 [bisher: CHF 214'416.00]. Liberierung Aktienkapital neu: CHF 436'133.00 [bisher: CHF 214'416.00]. Aktien neu: 436'133 Namenaktien zu CHF 1.00 [bisher: 95'127 Namenaktien zu CHF 1.00, 75'432 Namenaktien zu CHF 1.00 (Vorzugsaktien A1) und 43'857 Namenaktien zu CHF 1.00 (Vorzugsaktien A2)]. Statutarische Vorrechte neu: [Die statutarischen Vorrechte der 119'289 Namenaktien zu CHF 1.00 sind aufgehoben.] [gestrichen: Die Vorzugsaktien A1 und A2 gewähren Vorrechte bezüglich Liquidationserlös gemäss Statuten.].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1004854005 ↗

  2. SHAB published 13 Oct 2022 · legal date 7 Oct 2022

    Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    436’133 → 568’133
    Shares
    436’133 → 568’133
    New shares, % of post-step shares
    23.2% (132’000 new)

    Aktienkapital neu: CHF 568'133.00 [bisher: CHF 436'133.00]. Liberierung Aktienkapital neu: CHF 568'133.00 [bisher: CHF 436'133.00]. Aktien neu: 568'133 Namenaktien zu CHF 1.00 [bisher: 436'133 Namenaktien zu CHF 1.00].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005582175 ↗

  3. SHAB published 5 Aug 2026 · legal date 24 Jul 2026

    Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    568’133 → 649’294
    Shares
    568’133 → 649’294
    New shares, % of post-step shares
    12.5% (81’161 new)

    Aktienkapital neu: CHF 649'294.00 [bisher: CHF 568'133.00]. Liberierung Aktienkapital neu: CHF 649'294.00 [bisher: CHF 568'133.00]. Aktien neu: 649'294 Namenaktien zu CHF 1.00 [bisher: 568'133 Namenaktien zu CHF 1.00].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.74 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006724172 ↗

Published by 8 Oct 2026